Nuclear-Targeted Gold Nanoparticles Enhance Cancer Cell Radiosensitization
| dc.contributor.author | Pratx, Guillem | |
| dc.contributor.author | Özçelik, Serdar | |
| dc.coverage.doi | 10.1088/1361-6528/aba02b | |
| dc.date.accessioned | 2021-01-24T18:34:42Z | |
| dc.date.available | 2021-01-24T18:34:42Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Radiation therapy aims to kill or inhibit proliferation of cancer cells while sparing normal cells. To enhance radiosensitization, we developed 40 nm-sized gold nanoparticles targeting the nucleus. We exploited a strategy that combined RGD and NLS peptides respectively targeting cancer cell and the nucleus to initiate cell-death activated by x-ray irradiation. We observed that the modified gold nanoparticles were either translocated in the nuclei or accumulated in the vicinity of the nuclei. We demonstrated that x-ray irradiation at 225 kVp energy reduced cell proliferation by 3.8-fold when the nuclear targeted gold nanoparticles were used. We determined that the radiation dose to have a 10% survival fraction was reduced from 11.0 Gy to 7.1 Gy when 10.0 mu g ml(-1)of the NLS/RGD/PEG-AuNP was incubated with A549 cancer cells. We conclude that the peptide-modified gold nanoparticles targeting the nucleus significantly enhance radiosensitization. | en_US |
| dc.description.sponsorship | So thanks to Fulbright Commission for a scholarship partly supporting this work and Melek Ozkan Ucuncu, Ozge Tuncel, Secil Sevim Unluturk, Justin Klein, and Symantak Khan for their support. | en_US |
| dc.identifier.doi | 10.1088/1361-6528/aba02b | |
| dc.identifier.doi | 10.1088/1361-6528/aba02b | en_US |
| dc.identifier.issn | 0957-4484 | |
| dc.identifier.issn | 1361-6528 | |
| dc.identifier.scopus | 2-s2.0-85088624767 | |
| dc.identifier.uri | https://doi.org/10.1088/1361-6528/aba02b | |
| dc.identifier.uri | https://hdl.handle.net/11147/10409 | |
| dc.language.iso | en | en_US |
| dc.publisher | IOP Publishing | en_US |
| dc.relation.ispartof | Nanotechnology | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Gold nanoparticles | en_US |
| dc.subject | nuclear targeting | en_US |
| dc.subject | NLS peptide modification | en_US |
| dc.subject | Radiosensitization | en_US |
| dc.title | Nuclear-Targeted Gold Nanoparticles Enhance Cancer Cell Radiosensitization | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.institutional | Özçelik, Serdar | |
| gdc.bip.impulseclass | C4 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Institute of Technology. Chemistry | en_US |
| gdc.description.issue | 41 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q2 | |
| gdc.description.volume | 31 | en_US |
| gdc.description.wosquality | Q2 | |
| gdc.identifier.openalex | W3037921557 | |
| gdc.identifier.pmid | 32585647 | |
| gdc.identifier.wos | WOS:000553444700001 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 14.0 | |
| gdc.oaire.influence | 2.8959444E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.keywords | Cell Nucleus | |
| gdc.oaire.keywords | Radiation-Sensitizing Agents | |
| gdc.oaire.keywords | Cell Survival | |
| gdc.oaire.keywords | Nuclear Localization Signals | |
| gdc.oaire.keywords | Metal Nanoparticles | |
| gdc.oaire.keywords | Dose-Response Relationship, Radiation | |
| gdc.oaire.keywords | A549 Cells | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Gold | |
| gdc.oaire.keywords | Particle Size | |
| gdc.oaire.keywords | Oligopeptides | |
| gdc.oaire.keywords | Cell Proliferation | |
| gdc.oaire.popularity | 1.5797166E-8 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 2.31886449 | |
| gdc.openalex.normalizedpercentile | 0.89 | |
| gdc.openalex.toppercent | TOP 10% | |
| gdc.opencitations.count | 16 | |
| gdc.plumx.crossrefcites | 20 | |
| gdc.plumx.mendeley | 24 | |
| gdc.plumx.pubmedcites | 12 | |
| gdc.plumx.scopuscites | 18 | |
| gdc.scopus.citedcount | 18 | |
| gdc.wos.citedcount | 22 | |
| relation.isAuthorOfPublication.latestForDiscovery | ba0db351-faf1-4980-82bc-22e362fa795e | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9af2b05f-28ac-4011-8abe-a4dfe192da5e |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 10.1088@1361-6528@aba02b.pdf
- Size:
- 890.13 KB
- Format:
- Adobe Portable Document Format
